Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mucoid <i>Pseudomonas aeruginosa</i> is a marker of poor survival in cystic fibrosis

1 Mar 1992

Abstract excerpt

The aim of this study was to assess the prognostic significance of mucoid and non-mucoid isolates of Pseudomonas aeruginosa (muPs and non-muPs) from the sputa of patients with cystic fibrosis (CF). Eighty-one children with CF who coughed up sputum daily were recruited and followed over 12 months with frequent sputum cultures. At the end of this observation period they were classified to one of three age-matched...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cystic Fibrosis Research Advances
Share to Dysphagia Assessment and Management
Share to Tracheal and airway disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 1641272
DOI: 10.1002/ppul.1950120306

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mucoid <i>Pseudomonas aeruginosa</i> is a marker of poor survival in cystic fibrosisPMID 1641272Read ↗

Mucoid<i>Pseudomonas</i>in Cystic FibrosisSemantic proximity Read ↗

Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.Semantic proximity Read ↗

The effect ofPseudomonas aeruginosaon pulmonary function in patients with bronchiectasisSemantic proximity Read ↗

Small-Colony Variants of Pseudomonas aeruginosa in Cystic FibrosisSemantic proximity Read ↗

Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infectionSemantic proximity Read ↗

Predictors of mortality in adults with cystic fibrosis.Semantic proximity Read ↗

Risk factors for mortality in patients with Pseudomonas aeruginosa pneumonia: Clinical impact of mucA gene mutation.Semantic proximity Read ↗

Early rise of anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are risk factors for development of chronic lung infection--a case control study.Semantic proximity Read ↗

Biofilm differentiation and dispersal in mucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosisSemantic proximity Read ↗

Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.Semantic proximity Read ↗

BPI-ANCA Provides Additional Clinical Information to Anti-Pseudomonas Serology: Results from a Cohort of 117 Swedish Cystic Fibrosis Patients.Semantic proximity Read ↗

Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.